¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"platelet activating factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
platelet-activating factor
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óºÐºñ¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
scatter factor
»ê¶õ°è¼ö
stroma factor
¹öÆÀÁúÀÎÀÚ, °£ÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
sebotropic factor
Áö·çÃËÁøÀÎÀÚ
safety factor
¾ÈÀü°è¼ö
skin vascular permeability factor
ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
vascular permeability factor
Ç÷°üÅõ°úÀÎÀÚ
virulence factor
µ¶¼ºÀÎÀÚ, ¹ßº´ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
12
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
thyrotrophin releasing factor
¹æÆÐ»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ, °©»ó»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ
time-dose factor
½Ã°£¼±·®ÀÎÀÚ
tissue factor
Á¶Á÷ÀÎÀÚ
transfer factor
Àü´ÞÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
transmission factor
Åõ°ú°è¼ö
tumor angiogenesis factor
Á¾¾çÇ÷°üÇü¼ºÀÎÀÚ
tumor necrosis factor
Á¾¾ç±«»çÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
vascular permeability factor
Ç÷°üÅõ°úÀÎÀÚ
virulence factor
µ¶¼ºÀÎÀÚ, ¹ßº´ÀÎÀÚ
virus inhibitory factor
¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
growth hormone-releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
growth promoting factor
¼ºÀåÃËÁøÀÎÀÚ(à÷íþõµòäì×í), ¹ßÀ°ÃËÁø¹°Áú(Û¡ëÀõµòäÚªòõ)
hageman factor
ÇϰԸ¸ ÀÎÀÚ, Hageman ÀÎÀÚ
hematopoietic growth factor
Á¶Ç÷¼ºÀåÀÎÀÚ
hemorrhagic diathesis,clotting factor abnormalities
ÀÀ°íÀÎÀÚ ÀÌ»ó
hepatocyte growth factor
°£¼¼Æ÷¼ºÀåÀÎÀÚ
histamine sensitizing factor =HSF
È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡ÊïíÂì×í).
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
hyperglycemic glycogenolytic factor
°íÇ÷´ç¼º ´ç¿øºÐÇØ(¼º) ÀÎÀÚ.
hypothalamic releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í).
hypothalamic releasing factor
½Ã»óÇϺιæÃâÀÎÀÚ.
hypothalamus releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ.
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
intensity factor
°µµÀÎÀÚ
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
cytotoxic factor
¼¼Æ÷ µ¶¼º ÀÎÀÚ
decay-accelerating factor
ºÐÇØÃËÁøÀÎÀÚ
decay-accelerating factor (DAF)
ºØ±«ÃËÁøÀÎÀÚ
decay-accelerating factor(daf)
Decay-accelerating factor(DAF)
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ.
differentiation factor
°¨º°¿äÀÎ, °¨º°¿ä¼Ò, °¨º°ÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ(ÊÙËöËö), Èñ¼®ÀÎÀÚ.
dilution factor
¹±ÈûÀÎÀÚ(¡ì×í), Èñ¼®ÀÎÀÚ.
dose conversion factor
¼±·®º¯È¯°è¼ö
dose limiting factor
¼±·®ÇѵµÀÎÀÚ, ¼±·®Á¦ÇÑÀÎÀÚ
dose modifying factor
¼±·®¼ö½Ä°è¼ö
dose-reduction factor
¼±·®°¨¼Ò°è¼ö
drug resistance factor
¾àÁ¦³»¼ºÀÎÀÚ
drug resistance transfer factor
¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½